CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 61 filers reported holding CABALETTA BIO INC in Q4 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,616,596 | +17.9% | 2,340,118 | 0.0% | 0.78% | +21.7% |
| Q2 2023 | $30,210,923 | +686.9% | 2,340,118 | +404.1% | 0.64% | +650.0% |
| Q1 2023 | $3,839,364 | -10.6% | 464,252 | 0.0% | 0.09% | -3.4% |
| Q4 2022 | $4,294,331 | +1322.0% | 464,252 | 0.0% | 0.09% | +1383.3% |
| Q3 2022 | $302,000 | -38.6% | 464,252 | 0.0% | 0.01% | -40.0% |
| Q2 2022 | $492,000 | -47.8% | 464,252 | 0.0% | 0.01% | -52.4% |
| Q1 2022 | $942,000 | -46.5% | 464,252 | 0.0% | 0.02% | -43.2% |
| Q4 2021 | $1,760,000 | -68.8% | 464,252 | 0.0% | 0.04% | -66.4% |
| Q3 2021 | $5,645,000 | +41.4% | 464,252 | 0.0% | 0.11% | +54.9% |
| Q2 2021 | $3,993,000 | -22.5% | 464,252 | 0.0% | 0.07% | -34.3% |
| Q1 2021 | $5,153,000 | -11.1% | 464,252 | 0.0% | 0.11% | -6.1% |
| Q4 2020 | $5,794,000 | +15.1% | 464,252 | 0.0% | 0.12% | -6.5% |
| Q3 2020 | $5,032,000 | -2.7% | 464,252 | 0.0% | 0.12% | -18.5% |
| Q2 2020 | $5,172,000 | -44.8% | 464,252 | -63.9% | 0.15% | -49.3% |
| Q1 2020 | $9,375,000 | -58.8% | 1,284,313 | -21.1% | 0.30% | -59.0% |
| Q4 2019 | $22,750,000 | – | 1,628,504 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,106,000 | $32,053,320 | 21.20% |
| COMMODORE CAPITAL LP | 2,525,753 | $38,441,961 | 4.49% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $30,440,000 | 3.40% |
| VR Adviser, LLC | 1,973,253 | $30,032,911 | 3.16% |
| Cormorant Asset Management, LP | 2,879,424 | $43,824,833 | 2.56% |
| Velan Capital Investment Management LP | 150,000 | $2,283,000 | 1.84% |
| Redmile Group, LLC | 1,774,252 | $27,004,115 | 1.28% |
| TCG Crossover Management, LLC | 486,795 | $7,409,020 | 1.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,340,118 | $35,616,596 | 0.78% |
| Integral Health Asset Management, LLC | 330,000 | $5,022,600 | 0.70% |